Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational Results available

Observational Study for the Evaluation of Long-term Safety of Radium-223 Used for the Treatment of Metastatic Castration Resistant Prostate Cancer

ClinicalTrials.gov ID: NCT02141438

Public ClinicalTrials.gov record NCT02141438. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 2:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Radium-223 Alpha Emitter Agent in Non-intervention Safety Study in mCRPC popUlation for Long-teRm Evaluation

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Observational study in the routine clinical practice setting to evaluate the short and long term safety profile of Radium-223 in metastatic castration resistant prostate cancer patients and to evaluate the risk of developing second primary cancers.

Study identification

NCT ID
NCT02141438
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Bayer
Industry
Enrollment
1,472 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 20, 2014 (Actual)
Primary completion
Aug 2, 2024 (Actual)
Completion
Oct 24, 2024 (Actual)
Last update posted
Oct 16, 2025

2014 – 2024

United States locations

U.S. sites
49
U.S. states
30
U.S. cities
49
Facility City State ZIP Site status
Not listed Anchorage Alaska — —
Not listed Scottsdale Arizona — —
Not listed Daly City California — —
Not listed Long Beach California — —
Not listed Sacramento California — —
Not listed San Diego California — —
Not listed Colorado Springs Colorado — —
Not listed Boca Raton Florida — —
Not listed Fort Myers Florida — —
Not listed Jacksonville Florida — —
Not listed Lakewood Rch Florida — —
Not listed Plantation Florida — —
Not listed Atlanta Georgia — —
Not listed Decatur Georgia — —
Not listed Honolulu Hawaii — —
Not listed Evanston Illinois — —
Not listed Warrenville Illinois — —
Not listed Wichita Kansas — —
Not listed Ashland Kentucky — —
Not listed New Orleans Louisiana — —
Not listed Baltimore Maryland — —
Not listed Rockville Maryland — —
Not listed Towson Maryland — —
Not listed Boston Massachusetts — —
Not listed Troy Michigan — —
Not listed St Louis Missouri — —
Not listed Billings Montana — —
Not listed Omaha Nebraska — —
Not listed Lebanon New Hampshire — —
Not listed Neptune City New Jersey — —
Not listed Township New Jersey — —
Not listed Buffalo New York — —
Not listed East Setauket New York — —
Not listed Lake Success New York — —
Not listed Winston-Salem North Carolina — —
Not listed Middleburg Heights Ohio — —
Not listed Oklahoma City Oklahoma — —
Not listed Springfield Oregon — —
Not listed Abington Pennsylvania — —
Not listed Charleston South Carolina — —
Not listed Myrtle Beach South Carolina — —
Not listed Nashville Tennessee — —
Not listed Houston Texas — —
Not listed Lubbock Texas — —
Not listed San Antonio Texas — —
Not listed Temple Texas — —
Not listed Charlottesville Virginia — —
Not listed Virginia Beach Virginia — —
Not listed Seattle Washington — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02141438, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 16, 2025 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02141438 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →